Bargain Hunting with Jonathan Boyar
Barron's Live
00:00
What Is the Earnings and Pipeline Outlook for Johnson & Johnson?
Ben highlights J&J's recent stock gains, pipeline drugs, talc litigation overhang, and guidance watchers' expectations.
Play episode from 23:07
Transcript
